Bath & Body Works' (BBWI) Q3 results "unexpectedly delivered topline upside on core product strength," Morgan Stanley said in a report emailed Tuesday.
The investment bank said it now has an "incremental conviction" in the company's "ability to deliver at least +LSD% steady-state growth over time -- a positive development following our more uncertain view exiting 2Q."
Even after Bath & Body Works' share price gains on Monday its "valuation remains inexpensive" which indicates "ongoing room for re-rating closer to peers with similar financial profiles," the report said.
The re-rating opportunity combined with "clear momentum/positive rate of change in topline growth trends" plus the company's "relative tariff insulation vs. peers" and "attractive relative position" warrants the continuation of its overweight rating, Morgan Stanley said.
The investment firm raised Bath & Body Works' price target to $49 from $48.
Price: 34.72, Change: -1.06, Percent Change: -2.96
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。